Sign in

NCT06163534Recruiting

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
7 Nov 2023
Start date
1 Aug 2024
Primary completion date
1 Mar 2028
Lead sponsor
Tempus AI
NCT number
NCT06163534

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Aug 2024 to the primary completion date, 1 Mar 2028
  • 32 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Relapse or recurrence within 6 months of first line chemotherapy and / or chemoradiotherapy

Age

  • Clinical evidence of an active second invasive malignancy within \<2 years of enrollment with the exception of stable prostate cancer on watchful waiting, in situ cervical cancer, in situ breast carcinoma or localized non-melanoma skin cancers

Other

  • Non-squamous histologies (eg, nasopharynx or salivary gland)
  • Tumors that are PD-L1 negative (CPS \<1)
  • Unable to comply with study procedures (i.e., not willing or able to have additional blood samples collected)

Who the study is looking for

  • ≥18 years of age
  • Willing and able to provide informed consent
  • Histologically- or cytologically-confirmed metastatic or unresectable, recurrent HNSCC unsuitable for local therapies
  • Intended for first line anti-PD1 or PDL1 monotherapy or combination therapy
  • Must submit tumor tissue sample representative of current disease per laboratory manual

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (32)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pan American Cancer for Oncology
Coordinator of this site? Confirm its status
San JuanPuerto RicoActive, not recruiting
ThedaCare
Coordinator of this site? Confirm its status
AppletonUnited StatesRecruiting
Winship Cancer Institute, Emory University
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting
Morehouse
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting
Piedmont Healthcare
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting
University of Maryland
Coordinator of this site? Confirm its status
BaltimoreUnited StatesRecruiting
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Northwestern University Feinberg School of Medicine
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting
University of Cincinnati
Coordinator of this site? Confirm its status
CincinnatiUnited StatesRecruiting
Cleveland Clinic
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting
Ohio State University
Coordinator of this site? Confirm its status
ColumbusUnited StatesRecruiting
Cancer Care Specialists of Illinois
Coordinator of this site? Confirm its status
DecaturUnited StatesRecruiting
Henry Ford
Coordinator of this site? Confirm its status
DetriotUnited StatesRecruiting
Karmanos Cancer Institute
Coordinator of this site? Confirm its status
DetroitUnited StatesRecruiting
City of Hope
Coordinator of this site? Confirm its status
DuarteUnited StatesRecruiting
Sanford Fargo
Coordinator of this site? Confirm its status
FargoUnited StatesRecruiting
Mayo Clinic Florida
Coordinator of this site? Confirm its status
JacksonvilleUnited StatesRecruiting
USC / Norris Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting
University of California, Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting
Vanderbilt University
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting
Mount Sinai Hospital
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Stanford
Coordinator of this site? Confirm its status
Palo AltoUnited StatesRecruiting
Illinois Cancer Care
Coordinator of this site? Confirm its status
PeoriaUnited StatesRecruiting
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Mayo Clinic - Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting
Providence Medical Foundation
Coordinator of this site? Confirm its status
Santa RosaUnited StatesRecruiting
University of Washington
Coordinator of this site? Confirm its status
SeattleUnited StatesRecruiting
Sanford Sioux Falls
Coordinator of this site? Confirm its status
Sioux FallsUnited StatesRecruiting
Oncology Hematology Associates
Coordinator of this site? Confirm its status
SpringfieldUnited StatesRecruiting
Washington University in St. Louis
Coordinator of this site? Confirm its status
St LouisUnited StatesRecruiting
University of Kansas
Coordinator of this site? Confirm its status
WestwoodUnited StatesRecruiting
Cancer Care Associates of York
Coordinator of this site? Confirm its status
YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.